XTalks

JUNE 28, 2022

Intraosseous infusion of a drug is when a drug is administered into the bone marrow cavity which facilitates the delivery of the drug through a non-collapsible vein. Intraosseous infusion is reliable as it can aid in the delivery of a drug in a short time and has a great success rate in the first attempt.

Production 98

Production Drug Delivery Drugs Regulation 98

Drug Discovery World

MARCH 3, 2023

miRNAs are involved in the regulation of various physiological and pathological processes. In tumours, aberrant down regulation of given miRNAs may result in pathological overexpression of oncogenes, rendering miRNA replacement a promising therapeutic strategy. A major bottleneck in miRNA replacement is their efficient delivery.

Development 52

Development RNA Drug Delivery Regulation 52

BioPharma Reporter

MARCH 14, 2022

Novartisâ Sandoz has acquired UK-based medical and drug delivery device development company, Coalesce Product Development Limited.

Drug Delivery 52

Drug Delivery Production Development Drugs 52

pharmaphorum

MAY 4, 2022

The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, and large-volume drug products. As part of SAE Media Group’s leading injectable drug delivery portfolio, this event is not to be missed.

Drug Delivery 52

Drug Delivery Packaging Packaging Engineer 52

pharmaphorum

JULY 27, 2021

Drug delivery specialist Aptar Group has agreed a deal to take a near two-thirds share in Voluntis, a French developer of digital therapeutics (DTx), with a view to taking full control of the company later this year. per share in the initial deal, which will give it a 64.6% stake in the company.

Drug Delivery 111

Drug Delivery Insulin Cosmetics Development 111

pharmaphorum

JANUARY 18, 2022

The past year has seen significant developments in the injectables landscape with the rapid introduction and development of vaccines in response to the pandemic, updates in regulations including the EU MDR and FDA guidance on bridging studies, and increasing industry acceptance of connectivity to aid the user experience. Drug developers.

Drug Delivery 52

Drug Delivery Production Drug Delivery Systems Packaging 52

Roots Analysis

MARCH 8, 2023

Over time, various research studies have demonstrated the potential of exosomes ( membrane bound extracellular vesicles) in disease diagnosis, drug delivery and therapeutic applications. In addition, they are involved in regulating the expression of the targets that are linked to RNA as they can affect the expression of RNA.

RNA 52

RNA Drug Delivery DNA Development 52

Delveinsight

JANUARY 22, 2021

The launch of a novel drug in the market is not less than a celebration in the pharmaceutical and healthcare market; however, it also brings the real challenge of sustenance in the market. Similar is the picture of the Thrombocytopenia Drugs Market. Drug-Induced Thrombocytopenia, Gian Paolo Visentin, Chao Yan Liu).

Marketing 65

Marketing Drugs Antibody Compliance 65

The Pharma Data

NOVEMBER 9, 2020

Dr. Löbenberg holds Health Canada licences for research and analytical testing of a wide range of psychedelic compounds under the Controlled Drugs and Substance Act and research and analytical testing licences for cannabis under the Cannabis Act. . DMT (N,N-dimethyltryptamine). Prof. Dr. Löbenberg. ” Prof.

Development 40

Development Drugs Drug Delivery Production 40

Drug Discovery World

JUNE 7, 2023

s National Security and Investment Act, testimony to invoX’s continued willingness to build trust and work closely with regulators. McCarthy said: “At pHion Therapeutics, it is our mission to pioneer next generation, first-in-class vaccines for infectious disease and oncology through stealth-like delivery of mRNA.

Vaccination 52

Vaccination Vaccine Drug Delivery Systems Drug Delivery 52

FDA Law Blog

SEPTEMBER 19, 2023

The six-page statement explains that “Brand drug manufacturers may be harming generic competition through the improper listing of patents in the. Of course, the statute says that only drug formulation, composition, or method of use patents are listable, but FDA has not defined the scope of the “drug” that must be covered by the patent.

Drugs 105

Drugs Branding Drug Delivery Systems Generic Drugs 105

pharmaphorum

AUGUST 2, 2022

Roche’s Tecentriq could become the first drug in the PD-1/PD-L1 inhibitor class to be approved in a subcutaneous formulation, after the new version matched the original intravenous formulation in a phase 3 trial. Also coming through is Pfizer, which partners with Germany’s Merck KGaA on latecomer PD-L1 drug Bavencio (avelumab).

Trials 105

Trials Marketing Drugs Pharma Companies 105

Pharmaceutical Technology

OCTOBER 26, 2022

Nano-based delivery systems are on the rise, as they enable manufacturers to deliver therapeutic agents to specific targeted tissue in a more controlled manner. Data indicates that the global nanopharmaceutical drugs market size reached USD 53.85 Billion in 2021 and is expected to reach USD 102.4 Billion in 2030.

Manufacturing 130

Manufacturing Drug Delivery Systems Contamination Drug Delivery 130

The Pharma Data

NOVEMBER 2, 2020

The US Food and Drug Administration has twice designated psilocybin (4-phosphoryloxy-N,N-dimethyltryptamine) a “breakthrough therapy” for the treatment of severe and treatment-resistant depression due to its potential to provide a major improvement over currently available therapeutics for an unmet medical need.

Production 52

Production Development Drug Delivery Drugs 52

The Pharma Data

OCTOBER 27, 2020

On April 20, 2020, XPhyto announced a definitive development, technology purchase and licence agreement with 3a-Diagnostics for the development and commercialization of real-time, low-cost and easy-to-use screening tests using 3a’s pathogen specific biosensors and XPhyto’s oral dissolvable drug delivery platform.

RNA 52

RNA Drug Delivery Production In-Vitro 52

XTalks

OCTOBER 27, 2021

Genentech’s ocular implant drug delivery system for treatment of macular degeneration has received approval from the US Food and Drug Administration (FDA). Susvimo delivers ranibizumab via a port delivery system into a surgically placed implant in the eye, allowing for continuous delivery of the drug.

Drug Delivery Systems 104

Drug Delivery Systems Drug Delivery FDA Approval Drugs 104

Roots Analysis

OCTOBER 5, 2023

Driven by the increasing need for safe and efficient medical devices and drug delivery systems, the pharmaceutical polymers / medical grade polymers domain is advancing significantly. Vaccine Adjuvants: Polymers often serve as carriers for releasing the antigen and thereby regulating the immunological responses.

Manufacturing 40

Manufacturing Drug Delivery Systems Drug Delivery Packaging 40

The Pharma Data

DECEMBER 20, 2020

With this acquisition we are expanding our product pipeline to include psychedelic therapeutics, incorporating elements of our IP around drug delivery technology in which we already have prototypes developed, which we believe will propel us towards clinical studies relatively quickly. Ahmad Doroudian, CEO of BetterLife.

Drug Delivery 52

Drug Delivery Containment Production Development 52

pharmaphorum

JUNE 30, 2021

Shares in the biotech fell sharply after the decision was announced as investors fretted that the disappointment may read through to Altimmune’s plans for other intranasal vaccines – one of its two technology platforms alongside peptide-based drugs for liver diseases.

Vaccination 98

Vaccination Vaccine Trials Immune Response 98

Drug Discovery World

OCTOBER 18, 2023

Promising therapies are stumbling in clinical trials AAV vector-based gene therapies use modified viruses as drug delivery vehicles to effectively introduce DNA sequences into cells via transduction. Food & Drug Administration (2017) FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss.

Gene Therapy 64

Gene Therapy Gene Clinical Trials Clinical Trials 64

The Pharma Data

DECEMBER 14, 2020

While the medicalization of psychedelics is evolving and gaining momentum at an extraordinary pace, such therapeutics still face regulatory hurdles in the areas of manufacturing, formulating, and ultimately dispensing or the rescheduling of Schedule I drugs to patients. BetterLife Pharma Inc.

Drug Delivery 40

Drug Delivery Containment Manufacturing Drugs 40

The Pharma Data

JANUARY 18, 2021

According to Health Canada, “the information currently available at the Controlled Substances Directorate, 2-bromo-LSD is NOT CONTROLLED under the Schedules to the Controlled Drugs and Substances Act.”. BetterLife Pharma Inc.

Containment 40

Containment Regulation Production Drug Delivery 40

XTalks

AUGUST 30, 2022

According to an analysis of the 2013 Medical Expenditure Panel Survey, one in six US adults reported taking a psychiatric drug at least once in 2013. CNS drugs treat a range of neurologic and psychiatric disorders, such as psychosis, depression, Parkinson’s disease, multiple sclerosis and epilepsy.

Trials 83

Trials Drug Delivery Drugs Gene 83

The Pharma Data

DECEMBER 28, 2020

is an emerging biotechnology company engaged in the development and commercialization of therapeutic pharmaceuticals as well as drug delivery platform technologies. BetterLife Pharma Inc. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect.

Containment 52

Containment Drug Delivery Compliance Marketing 52

XTalks

JUNE 15, 2022

The featured speakers will discuss how life science manufacturers can now save time, money and resources and increase time to market by doing away with fully customized QMS solutions — while remaining compliant with industry regulations and standards. Royal Philips has been researching and developing treatment for critical limb ischemia.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drug Delivery 52

The Pharma Data

NOVEMBER 4, 2020

is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and phyto-therapeutic investment opportunities: precision transdermal and oral dissolvable drug dosage forms; rapid, low-cost infectious disease and oral health screening tools; and emerging plant-based therapeutics focused on European markets.

Drug Delivery 40

Drug Delivery Production Manufacturing Life Science 40

The Pharma Data

JANUARY 16, 2021

It has become the de facto standard equipment for high titer transient protein expression platforms used by many leading Chinese antibody drug pharmaceutical companies and IVD (In Vitro Diagnostics) companies since its launch in Oct. for non-viral cell immunotherapeutic drug development. About JS Bio.

Protein 52

Protein Production Antibody In-Vitro 52

Delveinsight

FEBRUARY 14, 2021

Caretakers and families of patients shell out thousands of dollars yearly to buy orphan drugs, as designated by the USFDA. Pharmaceutical companies sell their orphan drugs at astronomical prices such that many patients are not able to afford them. Therefore, rare disease patients were ‘orphaned’ by them and left without treatment.

Marketing 52

Marketing Clinical Trials Clinical Trials Trials 52

The Pharma Data

JANUARY 17, 2021

Clinical validation of transdermal and sublingual drug formulations. Psychedelic API production, drug formulation and clinical integration. Drug Formulations and Delivery. Commercialization of rapid COVID-19 PCR test. Diagnostics. “2020 was a very productive year for XPhyto. .

Production 40

Production Drug Delivery Development Drugs 40

The Pharma Data

NOVEMBER 26, 2020

As drug molecules become more complex so do the options to deliver them. There are significant challenges in drug development in this space and we look forward to working closely with pharma and biotech partners to discover how we can add value to their programs, provide patient benefit and competitive product differentiation.”

Containment 52

Containment Medicine Bioavailability Clinical Trials 52

The Pharma Data

JANUARY 3, 2021

The information in the press release is information that Nanoform is obliged to make public pursuant to the EU Market Abuse Regulation. The Company focuses on reducing attrition in clinical trials and on enhancing drug molecules’ formulation performance through its nanoforming services. . +46 7686 650 11. 2 Proof of Concept.

Containment 52

Containment Bioavailability Clinical Trials Clinical Trials 52

The Pharma Data

OCTOBER 27, 2020

DermSafe is listed by Health Canada under its approved products “ Disinfectants and hand sanitizers accepted under COVID-19 interim measure ” and has two Drug Identification Numbers (DIN) for personal use and personal commercial use. Statements have not been evaluated by Health Canada.

Sales 52

Sales Production Drug Delivery Development 52

XTalks

JULY 5, 2022

A corporate compliance training program is a part of many onboarding programs to ensure employees are up to date with the latest rules and regulations they must adhere to while working for the company. Clarification is key and the employees’ job requirements must be clearly communicated. Employee Compensation and Rewards.

Life Science 52

Life Science Compliance Packaging Packaging 52

Delveinsight

SEPTEMBER 2, 2021

On August 18, 2021, Abiomed received breakthrough device designation from the United States Food and Drug Administration (FDA) for its Impella ECP expandable percutaneous heart pump , the world’s smallest heart pump and the first to be compatible with small-bore access and closure techniques. Helius Medical Technologies, Inc.

Marketing 72

Marketing Radiology Drugs Drug Delivery 72

The Pharma Data

JANUARY 27, 2021

Construction of commercial drug manufacturing facility in Germany. Psychedelic transdermal and sublingual drug formulation development. Vektor will position itself for commercial manufacturing, pipeline development and drug formulations for critical mental health conditions.

Drugs 52

Drugs Manufacturing Drug Delivery Production 52

XTalks

MAY 30, 2023

The healthcare industry has one of the heaviest environmental footprints, and manufacturers are increasingly faced with regulations to make more sustainable products,” said Mohammad H. The patch itself is made of biodegradable nanocellulose and contains no plastic additives. Behfar, senior scientist at VTT, in the news release.

Drug Delivery 98

Drug Delivery Drug Delivery Systems Manufacturing Contamination 98

FDA Law Blog

JANUARY 5, 2023

Claud — As we turn into the New Year, we offer a few items of interest in digital and telehealth regulation, enforcement, and compliance that may provide some helpful guideposts for stakeholders. Combination products might be part drug, part device, or part software or hardware. By John W.M.

Regulation 59

Regulation Production Drug Delivery Insulin 59